- InspireMD entered equity distribution agreement with BTIG to sell up to USD 75 million of common stock in an at-the-market offering.
- BTIG will act as sales agent, earning commission up to 3% of gross proceeds.
- Net proceeds earmarked for operations, including R&D, sales and marketing, working capital.
- Prior USD 75 million ATM program with Piper Sandler was terminated effective April 3, 2026.
- InspireMD sold 1.36 million shares under Piper program before termination.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InspireMD Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-015127), on April 03, 2026, and is solely responsible for the information contained therein.
Comments